Understanding Coronary Artery Stenosis and the Limitations of Angiography

Coronary artery stenosis, the narrowing of the arteries supplying blood to the heart, is a hallmark of heart disease. For decades, doctors have used coronary angiography – an X-ray imaging technique – to visualize these blockages. However, angiography has limitations. It often struggles to accurately determine whether a narrowing is actually restricting blood flow enough to cause symptoms or pose a significant risk.

The Role of Fractional Flow Reserve (FFR)

Fractional flow reserve (FFR) addresses this challenge by directly measuring the pressure difference across a coronary artery stenosis. During an FFR test, a specialized catheter is advanced through the arteries to the blockage. A medication is then administered to simulate the physiological stress of exercise, allowing doctors to assess how significantly the narrowing impedes blood flow. A value of less than 0.80 generally indicates a hemodynamically significant blockage that warrants intervention.

FFR-Guided PCI: Improved Outcomes

Studies have consistently demonstrated that guiding percutaneous coronary intervention (PCI), commonly known as angioplasty with stenting, with FFR leads to superior results compared to relying solely on angiography or opting for medical therapy. Patients undergoing FFR-guided PCI experience fewer major adverse cardiac events, both in the short term and over the long term. But what if the invasive nature of FFR could be bypassed?

Angiography-Derived FFR: A Non-Invasive Alternative

Researchers have developed angiography-derived FFR (dFFR), a technique that estimates FFR using computational fluid dynamics applied to standard angiography images. This innovative approach eliminates the need for a pressure wire and hyperaemic agents, offering a less invasive and potentially more accessible method for assessing the functional significance of coronary artery disease. While not a perfect substitute, dFFR demonstrates a strong correlation with invasive, wire-based FFR.

Do you think wider adoption of FFR and dFFR could significantly reduce the number of unnecessary angioplasties performed each year? And how might these technologies impact the cost of cardiovascular care?

Further information on coronary artery disease can be found at the American Heart Association and the National Heart, Lung, and Blood Institute.

Frequently Asked Questions About FFR

1. What is fractional flow reserve (FFR) and how does it differ from angiography?

   FFR is a physiological test that measures blood flow through a narrowed artery, while angiography is an imaging test that only shows the anatomy of the artery. FFR determines if a blockage is actually causing a significant reduction in blood flow.

2. Is angiography-derived FFR (dFFR) as accurate as traditional FFR?

   dFFR shows good correlation with invasive FFR, but it’s not a perfect substitute. It offers a less invasive option, but the accuracy can vary depending on the complexity of the blockage and image quality.

3. Who is a good candidate for FFR testing?

   Patients with suspected coronary artery disease and intermediate findings on angiography are often candidates for FFR testing to help determine if intervention is necessary.

4. What are the benefits of FFR-guided PCI?

   FFR-guided PCI leads to better short-term and long-term outcomes, including a reduced risk of heart attack, repeat procedures, and death.

5. How does FFR help avoid unnecessary procedures?

   By accurately identifying which blockages are truly causing significant blood flow limitations, FFR can help doctors avoid stenting arteries that wouldn’t provide a clinical benefit.

6. What is the role of hyperaemic agents in FFR testing?

   Hyperaemic agents, like adenosine, are used to simulate the physiological stress of exercise, allowing doctors to accurately measure blood flow through the coronary arteries during FFR testing.